Value of Flemish Version of the Triage Risk Screening Tool in Predicting Unfavorable Outcomes After Elective Cancer Surgery: A Propensity Score-Matched Retrospective Cohort Study

Overview

Journal Biomed Hub

Specialty Biomedical Engineering

Date 2024 Apr 11

PMID 38601363

Authors

Shugo Yajima

Yasukazu Nakanishi

Ryo Andy Ogasawara

Naoki Imasato

Kohei Hirose

Sao Katsumura

Madoka Kataoka

Hitoshi Masuda

Affiliations

Soon will be listed here.

Abstract

Introduction: The Flemish version of the Triage Risk Screening Tool (fTRST), derived from the Triage Risk Screening Tool for assessing risk of readmission to the emergency department, is increasingly used as a simple screening tool in oncology. This study aimed to evaluate the utility of the fTRST in the context of elective surgical treatment for urologic cancer patients.

Methods: We included 886 patients who underwent major urologic cancer surgery at our institution between 2020 and 2022 and underwent preoperative screening, including fTRST. We set the fTRST cutoff at 2 and used propensity score matching and multivariate regression analysis to assess how fTRST affected two postoperative outcomes: ambulation failure and delirium.

Results: Of the 886 patients, 693 (78%) had an fTRST score <2, and 193 (22%) had an fTRST score ≥2 (high likelihood of frailty). After matching the groups by propensity scores, we compared the outcomes of 131 patients in each group. We found that the group with fTRST ≥2 had significantly higher rates of ambulation failure (15 vs. 11%, = 0.03) and delirium (16 vs. 11%, = 0.008) than the group with fTRST <2. Multivariate logistic regression analysis showed that fTRST score ≥2 was an independent risk factor for postoperative ambulation failure (odds ratio [OR] = 4.05, = 0.02), along with age ≥75 years (OR = 6.62, = 0.02), preoperative benzodiazepine medications (OR = 5.12, = 0.01), and receiving radical cystectomy (OR = 9.30, = 0.02). Similarly, for delirium, fTRST score ≥2 was an independent risk factor (OR = 2.88, = 0.03), along with preoperative benzodiazepine medications (OR = 4.38, = 0.002).

Conclusion: The fTRST might be a screening tool with great potential for identifying patients at high risk for unfavorable postoperative outcomes in elective urologic cancer surgery.

References

Karnakis T, Gattas-Vernaglia I, Saraiva M, Gil-Junior L, Kanaji A, Jacob-Filho W . The geriatrician's perspective on practical aspects of the multidisciplinary care of older adults with cancer. J Geriatr Oncol. 2016; 7(5):341-5. DOI: 10.1016/j.jgo.2016.07.001. View

Bellera C, Rainfray M, Mathoulin-Pelissier S, Mertens C, Delva F, Fonck M . Screening older cancer patients: first evaluation of the G-8 geriatric screening tool. Ann Oncol. 2012; 23(8):2166-2172. DOI: 10.1093/annonc/mdr587. View

Li X, Dai J, Zhao S, Liu W, Li H . Comparison of the value of Mini-Cog and MMSE screening in the rapid identification of Chinese outpatients with mild cognitive impairment. Medicine (Baltimore). 2018; 97(22):e10966. PMC: 6392520. DOI: 10.1097/MD.0000000000010966. View

Hara T, Matsuyama H, Kamiryo Y, Hayashida S, Yamamoto N, Nasu T . Use of preoperative performance status and hemoglobin concentration to predict overall survival for patients aged ≥ 75 years after radical cystectomy for treatment of bladder cancer. Int J Clin Oncol. 2015; 21(1):139-47. DOI: 10.1007/s10147-015-0857-9. View

Parker S, McCue P, Phelps K, McCleod A, Arora S, Nockels K . What is Comprehensive Geriatric Assessment (CGA)? An umbrella review. Age Ageing. 2017; 47(1):149-155. DOI: 10.1093/ageing/afx166. View

Braes T, Flamaing J, Sterckx W, Lipkens P, Sabbe M, de Rooij S . Predicting the risk of functional decline in older patients admitted to the hospital: a comparison of three screening instruments. Age Ageing. 2009; 38(5):600-3. DOI: 10.1093/ageing/afp097. View

Overcash J, Beckstead J, Extermann M, Cobb S . The abbreviated comprehensive geriatric assessment (aCGA): a retrospective analysis. Crit Rev Oncol Hematol. 2005; 54(2):129-36. DOI: 10.1016/j.critrevonc.2004.12.002. View

Mohile S, Dale W, Somerfield M, Schonberg M, Boyd C, Burhenn P . Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology. J Clin Oncol. 2018; 36(22):2326-2347. PMC: 6063790. DOI: 10.1200/JCO.2018.78.8687. View

Chen S, Chou W, Lin Y, Tsang N, Liao K, Lin C . Performance of two frailty screening tools among patients with cancer in Taiwan. Biomed J. 2022; 45(2):361-369. PMC: 9250070. DOI: 10.1016/j.bj.2021.03.002. View

10.

Meldon S, Mion L, Palmer R, Drew B, Connor J, Lewicki L . A brief risk-stratification tool to predict repeat emergency department visits and hospitalizations in older patients discharged from the emergency department. Acad Emerg Med. 2003; 10(3):224-32. DOI: 10.1111/j.1553-2712.2003.tb01996.x. View

11.

DeLong E, Delong D, Clarke-Pearson D . Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988; 44(3):837-45. View

12.

Hurria A, Mohile S, Dale W . Research priorities in geriatric oncology: addressing the needs of an aging population. J Natl Compr Canc Netw. 2012; 10(2):286-8. PMC: 3747652. DOI: 10.6004/jnccn.2012.0025. View

13.

van Walree I, Scheepers E, van Huis-Tanja L, Emmelot-Vonk M, Bellera C, Soubeyran P . A systematic review on the association of the G8 with geriatric assessment, prognosis and course of treatment in older patients with cancer. J Geriatr Oncol. 2019; 10(6):847-858. DOI: 10.1016/j.jgo.2019.04.016. View

14.

Mohile S, Bylow K, Dale W, Dignam J, Martin K, Petrylak D . A pilot study of the vulnerable elders survey-13 compared with the comprehensive geriatric assessment for identifying disability in older patients with prostate cancer who receive androgen ablation. Cancer. 2007; 109(4):802-10. DOI: 10.1002/cncr.22495. View

15.

Wildiers H, Heeren P, Puts M, Topinkova E, Janssen-Heijnen M, Extermann M . International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer. J Clin Oncol. 2014; 32(24):2595-603. PMC: 4876338. DOI: 10.1200/JCO.2013.54.8347. View

16.

Zattoni D, Montroni I, Saur N, Garutti A, Bacchi Reggiani M, Galetti C . A Simple Screening Tool to Predict Outcomes in Older Adults Undergoing Emergency General Surgery. J Am Geriatr Soc. 2018; 67(2):309-316. DOI: 10.1111/jgs.15627. View

17.

Borson S, Scanlan J, BRUSH M, Vitaliano P, Dokmak A . The mini-cog: a cognitive 'vital signs' measure for dementia screening in multi-lingual elderly. Int J Geriatr Psychiatry. 2000; 15(11):1021-7. DOI: 10.1002/1099-1166(200011)15:11<1021::aid-gps234>3.0.co;2-6. View

18.

Mainardi L, Borges T, Gomes T, Pichard C, Laviano A, Pimentel G . Association of SARC-F and dissociation of SARC-F + calf circumference with comorbidities in older hospitalized cancer patients. Exp Gerontol. 2021; 148:111315. DOI: 10.1016/j.exger.2021.111315. View

19.

Kenis C, Decoster L, Van Puyvelde K, De Greve J, Conings G, Milisen K . Performance of two geriatric screening tools in older patients with cancer. J Clin Oncol. 2013; 32(1):19-26. DOI: 10.1200/JCO.2013.51.1345. View

20.

Valenzuela C . [2 solutions for estimating odds ratios with zeros]. Rev Med Chil. 1993; 121(12):1441-4. View